Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Calls China No. 2 Market, Expands Footprint There With New Service, Lab Center

NEW YORK, Nov. 8 (GenomeWeb News) - Thermo Electron has opened a new customer service and demo laboratory center in Shanghai, China, the company said today.


The Waltham, Mass.-based company said that China has now become the company's second-largest market worldwide, representing more than 5 percent of its overall revenue.


The 43,000-square-foot facility will also house sales and marketing personnel and technical support and service for the region, Thermo said.


As GenomeWeb News sister publication BioCommerce Week reported in May, Thermo in December 2004 opened a 90,000-square-foot manufacturing facility in Shanghai that is slated to produce 10 products initially. Thermo also operates a manufacturing facility in JinQiao and has commercial locations in Beijing and Hong Kong as well as a newly opened office in Guangzhou.


Thermo also has commercial offices in Kunming, Chengdu, and Shenyang.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.